PAG
STLN

Private Advisor Group’s Starling Oncology Institute, Inc. Common Stock STLN Stock Holding History

Private Advisor Group’s Portfolio STLN Stock Details STLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$249K Sell
45,850
-48,320
-51% -$203K ﹤0.01% 2216
2026
Q1 		$289K Buy
94,170
+31,948
+51% +$98K ﹤0.01% 2204
2025
Q4 		$222K Sell
62,222
-6,700
-10% -$24.8K ﹤0.01% 2341
2025
Q3 		$241K Buy
+68,922
New +$236K ﹤0.01% 2223

Other funds holding STLN

Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
KWA
Kingswood Wealth Advisors San Diego, California $2.48B AUM 36.19% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
WPC
White Pine Capital Bloomington, Minnesota $423M AUM 67.01% 1-Year Est. Return
TC
T3 Companies New York $93.7M AUM
SOW
State of Wyoming Cheyenne, Wyoming $989M AUM 52.24% 1-Year Est. Return
IAAG
Innovative Asset Advisors Group Shelton, Connecticut $229M AUM
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Private Advisor Group's STLN Position: Q2 2026 in Review

Private Advisor Group reduced its Starling Oncology Institute, Inc. Common Stock (STLN) stake by 51% in Q2 2026, selling an estimated $203K and leaving 45,850 shares worth $249K. The position accounts for ﹤0.01% of the portfolio, ranked #2216.

Private Advisor Group first reported a position in STLN in Q3 2025 and has held it in 4 quarters since. The position peaked at $289K in Q1 2026. 29 funds tracked by Wall St. Rank hold STLN as of Q2 2026.

  • Private Advisor Group held 45,850 shares of Starling Oncology Institute, Inc. Common Stock worth $249K as of Q2 2026.
  • Private Advisor Group sold 48,320 Starling Oncology Institute, Inc. Common Stock shares in Q2 2026, an estimated $203K.
  • Starling Oncology Institute, Inc. Common Stock made up ﹤0.01% of Private Advisor Group's portfolio in Q2 2026, its #2216 holding.
  • Private Advisor Group first reported a position in Starling Oncology Institute, Inc. Common Stock in Q3 2025 and has held it in 4 quarters since.
  • Private Advisor Group's Starling Oncology Institute, Inc. Common Stock position peaked at $289K in Q1 2026.
  • 29 funds tracked by Wall St. Rank held Starling Oncology Institute, Inc. Common Stock as of Q2 2026.

Based on Private Advisor Group's 13F filing for Q2 2026, filed 27 Jul 2026.